Fresenius Medcl patents expiration
1. Phoslo patents expiration
| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US6576665 | FRESENIUS MEDCL | Encapsulated calcium acetate caplet and a method for inhibiting gastrointestinal phosphorous absorption |
Apr, 2021
(3 years ago) | |
Drugs and Companies using CALCIUM ACETATE ingredient
Market Authorisation Date: 02 April, 2001
Treatment: NA
Dosage: CAPSULE;ORAL
How can I launch a generic of PHOSLO before it's drug patent expiration?
More Information on Dosage
PHOSLO family patents
2. Phoslo Gelcaps patents expiration
| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US6576665 | FRESENIUS MEDCL | Encapsulated calcium acetate caplet and a method for inhibiting gastrointestinal phosphorous absorption |
Apr, 2021
(3 years ago) | |
| US6875445 | FRESENIUS MEDCL | Encapsulated calcium acetate caplet and a method for inhibiting gastrointestinal phosphorous absorption |
Jul, 2021
(2 years ago) | |
Drugs and Companies using CALCIUM ACETATE ingredient
Market Authorisation Date: 02 April, 2001
Treatment: NA
Dosage: CAPSULE;ORAL
How can I launch a generic of PHOSLO GELCAPS before it's drug patent expiration?
More Information on Dosage
PHOSLO GELCAPS family patents
3. Phoslyra patents expiration
PHOSLYRA Litigations
| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US8592480 | FRESENIUS MEDCL | Liquid compositions of calcium acetate |
Jul, 2027
(3 years from now) | |
| US9089528 | FRESENIUS MEDCL | Liquid compositions of calcium acetate |
Jul, 2027
(3 years from now) | |
| US8591938 | FRESENIUS MEDCL | Liquid compositions of calcium acetate |
Feb, 2030
(5 years from now) | |
Drugs and Companies using CALCIUM ACETATE ingredient
Market Authorisation Date: 18 April, 2011
Treatment: Use of phoslyra for reduction of serum phosphorous in patients
Dosage: SOLUTION;ORAL
How can I launch a generic of PHOSLYRA before it's drug patent expiration?
More Information on Dosage
PHOSLYRA family patents